Axplora, a German CDMO that specializes in specialty active pharmaceutical ingredients for small molecules and antibody-drug conjugates, will ...

North America: Largest market, powered by high drug consumption, strong regulatory frameworks, and advanced biotech manufacturing infrastructure. Asia Pacific: Fastest-growing, led by India's contract ...

Producing active pharmaceutical ingredients (API), raw materials of medicine, is urgent to save the country’s promising pharmaceuticals industry still heavily dependent on imports, industry insiders ...

Highly potent APIs (HPAPIs) are an increasingly important segment of the API market. While there are many contract development and manufacturing organizations (CDMOs) that claim to have potent ...

With plans to expand its domestic active pharmaceutical ingredient (API) production in the U.S., AbbVie will invest $195 million to build a new manufacturing facility in North Chicago, Illinois. This ...

After Zhejiang Huahai Pharmaceutical’s tainted valsartan API and Changchun Changsheng Life Sciences’ fabricated vaccine production data exposé, China’s drug industry could be dealing with another ...

ST. LOUIS--(BUSINESS WIRE)--The drug API Innovation Center today announced it has reached a milestone in the development of technology essential to accelerating the U.S. production of lomustine, a ...

Pakistan's pharmaceutical industry, valued at Rs. 748 billion, faces challenges with API imports. Localizing API production could enhance economic stability and healthcare affordability.

External manufacturing plays a crucial role in pharmaceutical companies’ supply strategy. The author examines market trends for the captive and merchant global market for active pharmaceutical ...

The Active Pharmaceutical Ingredients (API) Market plays a crucial role in the pharmaceutical industry, forming the backbone of drug development and production. APIs are the biologically active ...